Helmut Albrecht to Lamivudine
This is a "connection" page, showing publications Helmut Albrecht has written about Lamivudine.
Connection Strength
0.049
-
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
Score: 0.028
-
Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis. J Infect. 2010 Jan; 60(1):76-8.
Score: 0.021